Jieshi Medical key facts
- Manufacturers of class III medical devices and translational genomics aim to accelerate innovation in gene-based treatments and clinical translation of advanced therapeutics.
- Notable investors include Step Holdings, Win-Win Capital, Genuine Investment, Grand Yangtze Capital, Xingliang Investment — 6 tracked in total.
- Status: Privately Held (backing).
- ·Watch Jieshi Medical: the Monday email on marks, rounds and moves
Jieshi Medical funding rounds
No funding rounds for Jieshi Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Jieshi Medical investors
6 investors are on record for Jieshi Medical, including Step Holdings, Win-Win Capital, Genuine Investment and Grand Yangtze Capital.
About Jieshi Medical
Manufacturers of class III medical devices and translational genomics aim to accelerate innovation in gene-based treatments and clinical translation of advanced therapeutics. The company's primary operations include comprehensive gene research services, therapeutic target discovery and validation, and drug evaluation pipelines supporting cell and gene therapy development, enabling clients to streamline therapeutic development workflows, from target identification to early clinical stages, enhancing the pace and efficacy of bringing novel gene therapies.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2012
- Website
- sunvista.cn/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Jieshi Medical doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.